Ethical and legal framework and regulation for off-label use: European perspective
Open Access
- 1 July 2014
- journal article
- review article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. 10, 537-46
- https://doi.org/10.2147/tcrm.s40232
Abstract
Ethical and legal framework and regulation for off-label use: European perspective Christian Lenk,1 Gunnar Duttge2 1Institute for History, Theory and Ethics of Medicine, Ulm University, Ulm, Germany; 2Center for Medical Law, Göttingen University, Göttingen, Germany For more than 20 years the off-label use of drugs has been an essential part of the ethical and legal considerations regarding the international regulation of drug licensing. Despite a number of regulatory initiatives in the European Union, there seems to remain a largely unsatisfactory situation following a number of critical descriptions and statements from actors in the field. The present article gives an overview of the ethical and legal framework and developments in European countries and identifies existing problems and possible pathways for solutions in this important regulatory area. In addition to the presentation of the ethical and legal foundations, some attention is given to criticisms from medical practitioners to the current handling of off-label drug use. The review also focuses on the situation confronted by patients and physicians when off-label prescriptions are necessary. Through legal descriptions from a number of countries, possible solutions for future discussion of European health care policy are selected and explained. Keywords: ethics, law, Europe, health care policyKeywords
This publication has 12 references indexed in Scilit:
- Off-label prescribing in palliative care: A survey of independent prescribersPalliative Medicine, 2012
- Off-label drug use in paediatrics: a world-wide problem.Current Drug Targets, 2012
- Reforming Off-Label Promotion to Enhance Orphan Disease TreatmentScience, 2010
- Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatricsEuropean Journal of Pediatrics, 2009
- Defining off-label and unlicensed use of medicines for children: Results of a Delphi surveyPharmacological Research, 2008
- The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)Annals of Oncology, 2007
- Paediatric clinical pharmacology—at the beginning of a new eraEuropean Journal of Clinical Pharmacology, 2007
- A One-Day Survey of Characteristics of Off-Label Hospital Prescription of Psychotropic DrugsPharmacopsychiatry, 2007
- „Off-label” Verschreibung von Arzneimitteln in der ambulanten Versorgung von Kindern und JugendlichenDeutsche Medizinische Wochenschrift (1946), 2002
- Off label and unlicensed drug use among French office based paediatriciansArchives of Disease in Childhood, 2000